SEC Form 4 · accession 0001574774-18-000056
BIOTELEMETRY, INC. · BEAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fred Broadway
Officer — President BioTel Heart
Period of report
Sep 28, 2018
Accepted (ET)
Oct 2, 2018 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001574774
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 28, 2018 | M | 39,238 | $4.67 | A | 64,118 | D | |
| Common Stock | Sep 28, 2018 | M | 26,963 | $2.80 | A | 91,081 | D | |
| Common Stock | Sep 28, 2018 | M | 23,912 | $2.54 | A | 114,993 | D | |
| Common Stock | Sep 28, 2018 | S | 90,113 | $65.00 | D | 24,880 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F2 | $4.67 | Sep 28, 2018 | M | 39,238 | D | — | Mar 4, 2021 | Common Stock | 39,238 | 0 | D |
| Stock Options (Right to Buy)F3 | $2.80 | Sep 28, 2018 | M | 26,963 | D | — | Feb 21, 2022 | Common Stock | 26,963 | 0 | D |
| Stock Options (Right to Buy)F4 | $2.54 | Sep 28, 2018 | M | 23,912 | D | — | Feb 19, 2023 | Common Stock | 23,912 | 0 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2018.
- F2The options were fully exercisable on December 31, 2014.
- F3The options were fully exercisable on December 31, 2015.
- F4The options were fully exercisable on February 19, 2017.